Iron deficiency without anaemia: Do not wait for the haemoglobin to drop?

Health Policy and Technology

Volumn 2, Issue 1, 2013, Pages 45-58

  Rattehalli, Deepa ^a   Pickard, Lucy ^a   Tselepis, Chris ^b   Sharma, Naveen ^a   Iqbal, Tariq H ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS FUMARATE; FERROUS SULFATE; HEMOGLOBIN; IRON; PLACEBO; ZINC OXIDE;

COGNITION; ENDURANCE; FATIGUE; HEART FAILURE; HUMAN; IRON DEFICIENCY; IRON DEFICIENCY WITHOUT ANEMIA; IRON METABOLISM; IRON THERAPY; IRON TRANSPORT; PATIENT COMPLIANCE; PERINATAL PERIOD; PHYSICAL PERFORMANCE; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; TODDLER;

EID: 84873077474     PISSN: 22118837     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlpt.2012.12.005     Document Type: Review

References (121)

1. de Benoist B, McLean E, Egli I et al. Worldwide prevalence of anaemia 1993-2005. WHO global database on anaemia. Accessed Feb 2012. Available at URL: http://www.who.int/vmnis/publications/anaemia_prevalence/en/index.html.
2. Yu Y, Kovacevic Z, Richardson DR Tuning cell cycle regulation with an iron key. Cell Cycle 2007, 16:1982-1994.
3. Weiss G, Goodnough LT Anemia of chronic disease. The New England Journal of Medicine 2005, 352:1011-1023.
4. Goddard AF, James MW, McIntyre AS, et al. Guidelines for the management of iron deficiency anaemia. Gut 2011, 60:1309-1316.
5. http://www.who.int/nutrition/publications/micronutrients/anaemia_iron.
6. Yavuz BB, Cankurtaran M, Haznedaroglu IC, et al. Iron deficiency can cause cognitive impairment in in geriatric patients. The Journal of Nutrition Health and Aging 2012, 16:220-224.
7. Lozoff B, Beard J, Connor J, Felt B, Georgieff M, Schallert T Long-lasting neural and behavioral effects of early iron deficiency in infancy. Nutrition Reviews 2006, 64(Suppl):S34-S43.
8. Georgieff M Long-term brain and behavioural consequences of early iron deficiency. Nutrition Reviews 2011, 69(1):S43-S48.
9. Carlson ES, Tkac I, Magid R, O'Connor MB, Andrews NC, Schallert T, et al. Iron is essential for neuron development and memory function in mouse hippocampus. Journal of Nutrition 2009, 139:672-679.
10. Dwork AJ, Lawler G, Zybert PA, Durkin M, Osman M, Willson N, et al. An autoradiographic study of the uptake and distribution of iron by the brain of the young rat. Brain Research 1990, 518:31-39.
11. Aoki S, Okada Y, Nishimura K, Barkovich AJ, Kjos BO, Brasch RC, et al. Normal deposition of brain iron in childhood and adolescence: MR imaging at 1.5T. Radiology 1989, 172:381-385.
12. Erikson KM, et al. Regional brain iron, ferritin, and transferrin concentrations during iron deficiency and iron repletion in developing rats. Journal of Nutrition 1997, 127(10):2030-2038.
13. Beard J Iron deficiency alters brain development and functioning. The American Society for Nutritional Sciences Journal of Nutrition 2003, 133:1468S-1472S.
14. Wu L, Zhang L, Shao J, Qin Y, Yang R, Zhao Z Effect of perinatal iron deficiency on myelination and associated behaviours in rat pups. American Journal of Pathology 1986, 125(3):620-624. December.
15. Lozoff B, et al. Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics 2000, 105(4):E51.
16. Shafir T, Angulo-Barroso R, Calatroni A, Jimenez E, Lozoff B Effects of iron deficiency on patterns of motor development over time. Human Movement Science 2006, 25:821-838.
17. Gunnarsson BS, Thorsdottir I, Palsson G, Gretarsson SJ Iron status and 1 and 6 years versus developmental scores at 6 years in a well-nourished affluent population. Acta Paediatrica 2007, 96:391-395.
18. Grantham-Mcgregor S, Ani C A review of studies on the effect of iron deficiency on cognitive development in children. Journal of Nutrition 2011, 131:649S-668S.
19. Lozoff B, Wolf AW, Urrutia J, Viteri F Abnormal behaviour and low developmental test scores in iron deficient anemic infants. Journal of Developmental & Behavioral Pediatrics 1985, 6:69-75.
20. Georgieff M, Petry K, Wobken J, Oyer C Liver and brain iron defiency in newborn infants with bilateral renal agenesis (potters syndrome). Pediatric Pathology 1996, 16:509-519.
21. Petry C, Wobken J, McKay H, Eaton M, Seybold V, Johnson D, et al. Placental transferrin receptor in diabetic pregnancies with increased fetal iron demand. American Journal of Pathology 1994, 267:E507-E514.
22. Petry C, Eaton M, Wobken J, Mills M, Johnson D, Georgieff M Iron deficiency of liver, heart and brain in newborn infants of diabetic mothers. Journal of Pediatrics 1992, 121:109-114.
23. Tamura T, Goldenberg RL, Hou J, et al. Cord serum ferritin concentrations and mental and psychomotor development of children at five years of age. Journal of Pediatrics 2002, 140:165-170.
24. Preziosi P, Praul A, Galan P, Daodud H, Boureima H, Herberg S Effect of iron supplementation on the iron status of pregnant women: consequences for newborns. The American Journal of Clinical Nutrition 1997, 66(5):1178-1182.
25. Wachs TD, Pollitt E, Cuerto S, et al. Relation of neonatal iron status to individual variability in neonatal temperament. Developmental Psychobiology 2005, 46:141-153.
26. Oski FA, Helu B, Howanitz P Effect on iron therapy on behavior performance in nonanaemic, iron deficient infants. Pediatrics 1983, 71:877-880.
27. Riggins T, Miller NC, Bauer PB, Georgieff MK, Nelson CA Consequences of low neonatal iron status due to maternal diabetesmellitus on explicit memory performance in childhood. Developmental Neuropsychology 2009, 34:762-779.
28. Algarin C, Peirano P, Garrido M, Pizarro F, Lozoff B Iron deficiency anemia in infancy: long-lasting effects on auditory and visual systems functioning. Pediatric Research 2003, 53:217-223.
29. WHO/UNICEF/Joint Committee on Health Policy Strategic approach to operationalizing selected end-decade goals: reduction of iron deficiency anaemia. UNICEF-WHO Joint Committee on Health Policy editor. JCHP30/95/4.5 1-8. 1994 Geneva WHO.
30. Freire WB Strategies of the Pan American Health Organization/World Health Organization for the control of iron deficiency in Latin America. Nutrition Reviews 1997, 55:183-188.
31. Krebs NF, Hambidge KM Complementary feeding: clinically relevant factors affecting timing and composition. The American Journal of Clinical Nutrition 2007, 85(Supppl):S639-S645.
32. Lukowski AF, Koss M, Burden MJ, et al. Iron deficiency in infancy and neurocognitive functioning at 19 years: evidence of long-term deficits in executive function and recognition memory. Nutritional Neuroscience 2010, 13:54-70.
33. Lozoff B, et al. Dose-response relationships between iron deficiency with or without anemia and infant social-emotional behaviour. Journal of Pediatrics. 152 2008, 5(696-702):33. May.
34. Carter RC, Jacobson JL, Burden MJ, Armony-Sivan R, Dodge NC, Angelilli ML, et al. Iron deficiency and cognitive function in infancy. Pediatrics 2010, 126:e427-e434.
35. Lozoff B Behavioural alterations in iron deficiency. Advances in Pediatrics 1988, 35:331-359.
36. Kordas K, Slotzfus R, Lopez P et al. Iron and zinc supplementation does not improve parent or teacher ratings of behaviour in first grade Mexican children exposed to lead.
37. Bruner AB, et al. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet 1996, 348(9033):992-996.
38. Pollitt E, et al. Iron deficiency and educational achievement in Thailand. Journal of Clinical Nutrition 1989, 50(3 Suppl):687-696.
39. Sungthong R, Mo-Suwan L, Chongsuvivatwong V, Geater AF Once-weekly and 5-days a week iron supplementation differentially affect cognitive function but not school performance in Thai children. The Journal of Nutrition 2004, 134:2349-2354.
40. Alkingham M, Abdelhamid A, Curtis P, et al. The effects of oral iron supplementation oncognition in older children and adults: a systematic review and meta-analysis. Nutrition Journal 2010, 25(9:4). Jan.
41. Cogswell M, Looker A, Cook J, et al. Assessment of iron deficiency in US preschool children and non pregnant females of childbearing age: National Health and Nutrition Examination Survey 2003-2006. The American Journal of Clinical Nutrition 2009, 89:1334-1342.
42. Murray-Kolb LE, Beard JL Iron treatment normalizes cognitive functioning in young adult women. The American Journal of Clinical Nutrition 2007, 85:778-787.
43. Beutler E, Larsh SE, Gurney CW Iron therapy in chronically fatigued, nonanemic women: a double-blind study. Annals of Internal Medicine 1960, 52:378-394.
44. Verdon F, Burnand B, Stubi CL, Bonard C, Graff M, Michaud A, et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomized placebo controlled trial. British Medical Journal 2003, 326:1124.
45. Patterson AJ, Brown WJ, Roberts DCK Dietary and supplement treatment of iron deficiency results in improvements in general health and fatigue in Australian women of childbearing age. Journal of the American College of Nutrition 2001, 20:337-342.
46. Groner JA, Holtzman NA, Charney E, Mellits ED A randomized trial of oral iron on tests of short-term memory and attention span in young pregnant women. Journal of Adolescent Health Care 1986, 7:44-48.
47. Krayenbuehl P-A, Bettagay E, Braymann C, et al. Blood 2011, 118:3222-3227.
48. Beard J, Tobin B Iron status and exercise. The American Journal of Clinical Nutrition 2000, 72(2 Suppl):594S-597SS.
49. Rowland TW, Black SA, Kelleher JF Iron deficiency in adolescent endurance athletes. Journal of Adolescent Health Care 1987, 8(4):322-326.
50. Spodaryk K Iron metabolism in boys involved in intensive physical training. Physiology & Behavior 2002, 75(1-2):201-206.
51. Clement DB, Lloyd-Smith DR, Macintyre JG, et al. Iron status in winter olympic sports. Journal of Sports Sciences 1987, 5(3):261-271.
52. Wishnitzer R, Vorst E, Berrebi A Bone marrow iron depression in competitive distance runners. International Journal of Sports Medicine 1983, 4(1):27-30.
53. Magazanik A, Weinstein Y, Dlin RA, et al. Iron deficiency caused by 7 weeks of intensive physical exercise. European Journal of Applied Physiology and Occupational Physiology 1988, 57(2):198-202.
54. Sinclair LM, Hinton PS Prevalence of iron deficiency with and without anemia in recreationally active men and women. Journal of the American Dietetic Association 2005, 105(6):975-978.
55. Murray-Kolb LE, Beard JL, Joseph LJ, et al. Resistance training affects iron status in older men and women. The International Journal of Sport Nutrition and Exercise Metabolism 2001, 11(3):287-298.
56. DeRuisseau KC, Roberts LM, Kushnick MR, et al. Iron status of young males and females performing weight-training exercise. Medicine & Science in Sports & Exercise 2004, 36(2):241-248.
57. Dubnov G, Foldes AJ, Mann G, et al. High prevalence of iron deficiency and anemia in female military recruits. Military Medicine 2006, 171(9):866-869.
58. McClung JP, Marchitelli LJ, Friedl KE, et al. Prevalence of iron deficiency and iron deficiency anemia among three populations of female military personnel in the US Army. Journal of the American College of Nutrition 2006, 25(1):64-69.
59. Weight LM, Jacobs P, Noakes TD Dietary iron deficiency and sports anaemia. British Journal of Nutrition 1992, 68(1):253-260.
60. Haymes EM, Spillman DM Iron status of women distance runners, sprinters, and control women. International Journal of Sports Medicine 1989, 10(6):430-433.
61. Miller BJ, Pate RR, Burgess W Foot impact force and intravascular hemolysis during distance running. International Journal of Sports Medicine 1988, 9(1):56-60.
62. Telford RD, Sly GJ, Hahn AG, et al. Footstrike is the major cause of hemolysis during running. Journal of Applied Physiology 2003, 94(1):38-42.
63. Selby GB, Eichner ER Endurance swimming, intravascular hemolysis, anemia, and iron depletion. New perspective on athlete's anemia. American Journal of Medicine 1986, 81(5):791-794.
64. Reeder BJ, Wilson MT Hemoglobin and myoglobin associated oxidative stress: from molecular mechanisms to disease States. Current Medicinal Chemistry 2005, 12(23):2741-2751.
65. McInnis MD, Newhouse IJ, von Duvillard SP, et al. The effect of exercise intensity on hematuria in healthy male runners. European Journal of Applied Physiology and Occupational Physiology 1998, 79(1):99-105.
66. Blacklock NJ Bladder trauma in the long-distance runner: 10,000m haematuria. British Journal of Urology 1977, 49(2):129-132.
67. Waller MF, Haymes EM The effects of heat and exercise on sweat iron loss. Medicine and Science in Sports and Exercise 1996, 28(2):197-203.
68. Paulev PE, Jordal R, Pedersen NS Dermal excretion of iron in intensely training athletes. Clinica Chimica Acta 1983, 127(1):19-27.
69. Otte JA, Oostveen E, Geelkerken RH, et al. Exercise induces gastric ischemia in healthy volunteers: a tonometry study. Journal of Applied Physiology 2001, 91(2):866-871.
70. Peters HP, De Vries WR, Vanberge-Henegouwen GP, et al. Potential benefits and hazards of physical activity and exercise on the gastrointestinal tract. Gut 2001, 48(3):435-439.
71. Gaudin C, Zerath E, Guezennec CY Gastric lesions secondary to long-distance running. Digestive Diseases and Sciences 1990, 35(10):1239-1243.
72. Rudzki SJ, Hazard H, Collinson D Gastrointestinal blood loss in triathletes: it's etiology and relationship to sports anaemia. Australian Journal of Science and Medicine in Sport 1995, 27(1):3-8.
73. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306(5704):2090-2093.
74. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. The Journal of Clinical Investigation 2004, 113(9):1271-1276.
75. Kemna E, Pickkers P, Nemeth E, et al. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005, 106(5):1864-1866.
76. Ostrowski K, Rohde T, Asp S, et al. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. The Journal of Physiology 1999, 515(Pt 1):287-291.
77. Margeli A, Skenderi K, Tsironi M, et al. Dramatic elevations of interleukin-6 and acute-phase reactants in athletes participating in the ultradistance foot race spartathlon: severe systemic inflammation and lipid and lipoprotein changes in protracted exercise. The Journal of Clinical Endocrinology & Metabolism 2005, 90(7):3914-3918.
78. Roecker L, Meier-Buttermilch R, Brechtel L, et al. Iron-regulatory protein hepcidin is increased in female athletes after a marathon. European Journal of Applied Physiology 2005, 95(5-6):569-571.
79. Peeling P, Dawson B, Goodman C, et al. Cumulative effects of consecutive running sessions on hemolysis, inflammation and hepcidin activity. European Journal of Applied Physiology 2009, 106(1):51-59.
80. Banzet S, Sanchez H, Chapot R, et al. Interleukin-6 contributes to hepcidin mRNA increase in response to exercise. Cytokine 2012, 58(2):158-161.
81. Newlin MK, Williams S, McNamara T, et al. The effects of acute exercise bouts on hepcidin in women. International Journal of Sport Nutrition and Exercise Metabolism 2012, 22(2):79-88.
82. Fallon KE The acute phase response and exercise: the ultramarathon as prototype exercise. Clinical Journal of Sport Medicine 2001, 11(1):38-43.
83. LaManca JJ, Haymes EM Effects of low ferritin concentration on endurance performance. International Journal of Sport Nutrition 1992, 2(4):376-385.
84. DellaValle DM, Haas JD Impact of iron depletion without anemia on performance in trained endurance athletes at the beginning of a training season: a study of female collegiate rowers. International Journal of Sport Nutrition and Exercise Metabolism 2011, 21(6):501-506.
85. Rowland TW, Deisroth MB, Green GM, et al. The effect of iron therapy on the exercise capacity of nonanemic iron-deficient adolescent runners. American Journal of Diseases of Children 1988, 142(2):165-169.
86. Hinton PS, Sinclair LM Iron supplementation maintains ventilatory threshold and improves energetic efficiency in iron-deficient nonanemic athletes. European Journal of Clinical Nutrition 2007, 61(1):30-39.
87. Zhu YI, Haas JD Iron depletion without anemia and physical performance in young women. The American Journal of Clinical Nutrition 1997, 66(2):334-341.
88. Friedmann B, Weller E, Mairbaurl H, et al. Effects of iron repletion on blood volume and performance capacity in young athletes. Medicine & Science in Sports & Exercise 2001, 33(5):741-746.
89. McClung JP, Karl JP, Cable SJ, et al. Randomized, double-blind, placebo-controlled trial of iron supplementation in female soldiers during military training: effects on iron status, physical performance, and mood. The American Journal of Clinical Nutrition 2009, 90(1):124-131.
90. Zhu YI, Haas JD Altered metabolic response of iron-depleted nonanemic women during a 15-km time trial. Journal of Applied Physiology 1998, 84(5):1768-1775.
91. LaManca JJ, Haymes EM Effects of iron repletion on VO2max, endurance, and blood lactate in women. Medicine & Science in Sports & Exercise 1993, 25(12):1386-1392.
92. Hinton PS, Giordano C, Brownlie T, et al. Iron supplementation improves endurance after training in iron-depleted, nonanemic women. Journal of Applied Physiology 2000, 88(3):1103-1111.
93. Brownlie T, Utermohlen V, Hinton PS, et al. Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women. The American Journal of Clinical Nutrition 2002, 75(4):734-742.
94. Brownlie T, Utermohlen V, Hinton PS, et al. Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. The American Journal of Clinical Nutrition 2004, 79(3):437-443.
95. Lukaski HC, Hall CB, Siders WA Altered metabolic response of iron-deficient women during graded, maximal exercise. European Journal of Applied Physiology and Occupational Physiology 1991, 63(2):140-145.
96. Klingshirn LA, Pate RR, Bourque SP, et al. Effect of iron supplementation on endurance capacity in iron-depleted female runners. Medicine & Science in Sports & Exercise 1992, 24(7):819-824.
97. Peeling P, Blee T, Goodman C, et al. Effect of iron injections on aerobic-exercise performance of iron-depleted female athletes. International Journal of Sport Nutrition and Exercise Metabolism 2007, 17(3):221-231.
98. Fogelholm M, Jaakkola L, Lampisjarvi T Effects of iron supplementation in female athletes with low serum ferritin concentration. International Journal of Sports Medicine 1992, 13(2):158-162.
99. Karamizrak SO, Islegen C, Varol SR, et al. Evaluation of iron metabolism indices and their relation with physical work capacity in athletes. British Journal of Sports Medicine 1996, 30(1):15-19.
100. Powell PD, Tucker A Iron supplementation and running performance in female cross-country runners. International Journal of Sports Medicine 1991, 12(5):462-467.
101. Matter M, Stittfall T, Graves J, et al. The effect of iron and folate therapy on maximal exercise performance in female marathon runners with iron and folate deficiency. Clinical Science (London) 1987, 72(4):415-422.
102. Groenveld HF, Januzzi JL, Damman K, et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. Journal of the American College of Cardiology 2008, 52(10):818-827.
103. de Silva R, Rigby AS, Witte KK, et al. Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. American Journal of Cardiology 2006, 98(3):391-398.
104. Anas JN, Matsouka C, Karageorgopoulos D, et al. Etiology of anemia in patients with advanced heart failure. Journal of the American College of Cardiology 2006, 48(12):2485-2489.
105. Jankowska EA, Rozentryt P, Witkowska A, et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. European Heart Journal 2010, 31(15):1872-1880.
106. Jankowska EA, Rozentryt P, Witkowska A, et al. Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. Journal of Cardiac Failure 2011, 17(11):899-906.
107. Anker SD, Sharma R The syndrome of cardiac cachexia. International Journal of Cardiology 2002, 85(1):51-66.
108. Mann DL, Young JB Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest 1994, 105(3):897-904.
109. Martinez-Ruiz A, Tornel-Osorio PL, Sanchez-Mas J, et al. Soluble TNFalpha receptor Type I and Hepcidin as determinants of development of anemia in the long-term follow-up of heart failure patients. Clinical Biochemistry 2012.
110. Macdougall IC, Tucker B, Thompson J, et al. A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney International 1996, 50(5):1694-1699.
111. Van Wyck DB, Roppolo M, Martinez CO, et al. A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. Kidney International 2005, 68(6):2846-2856.
112. Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. Journal of the American College of Cardiology 2000, 35(7):1737-1744.
113. Comin-Colet J, Ruiz S, Cladellas M, et al. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes. Journal of Cardiac Failure 2009, 15(9):727-735.
114. Bolger AP, Bartlett FR, Penston HS, et al. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. Journal of the American College of Cardiology 2006, 48(6):1225-1227.
115. Usmanov RI, Zueva EB, Silverberg DS, et al. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. Journal of Nephrology 2008, 21(2):236-242.
116. Toblli JE, Lombrana A, Duarte P, et al. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. Journal of the American College of Cardiology 2007, 50(17):1657-1665.
117. Okonko DO, Grzeslo A, Witkowski T, et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. Journal of the American College of Cardiology 2008, 51(2):103-112.
118. Anker SD, Comin CJ, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. The New England Journal of Medicine 2009, 361(25):2436-2448.
119. Comin-Colet J, Lainscak M, Dickstein K, et al. The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study. European Heart Journal 2012.
120. Krafft A, Perewusnyk G, Hänseler E, Quack K, Huch R, Breymann C Effect of postpartum iron supplementation on red cell and iron parameters in non-anaemic iron deficient women: a randomised placebo-controlled study. BJOG 2005, 112:445-450.
121. Moore RA, Gasiell H, Rose P, allan J Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published data. BMC Blood Disorders 2001, 11:4.